Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

Cancer vaccines harness the power of the immune system to stop tumors in their tracks. They work a little differently than ...

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...

The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Penn researchers are developing new treatments using mRNA technology to combat a range of diseases, namely celiac disease ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...